Skip to Main Content

Author Details

Ruby Yun-Ju Huang
National Taiwan University College of Medicine
2008
69
32
PMIDPaper TitleJournal TitlePublished Year
36629283Immune-Hot tumor features associated with recurrence in early-stage ovarian clear cell carcinoma.Int J Cancer2023
37664030Prognosis signature for predicting the survival and immunotherapy response in esophageal carcinoma based on cellular senescence-related genes.Front Oncol2023
37349576The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer.Commun Biol2023
37080839Nodal reactive proliferation of monocytoid B-cells may represent atypical memory B-cells.J Microbiol Immunol Infect2023
37474650Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer.Commun Biol2023
33780951Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies.Cells Tissues Organs2022
356375173D genome organization in the epithelial-mesenchymal transition spectrum.Genome Biol2022
35574327A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma.Front Oncol2022
36612187The CAM Model-Q&A with Experts.Cancers (Basel)2022
33391524Putting the BRK on breast cancer: From molecular target to therapeutics.Theranostics2021
33625616Prognostic significance of phosphoglycerate dehydrogenase in breast cancer.Breast Cancer Res Treat2021
33506832High-throughput functional profiling of single adherent cells <i>via</i> hydrogel drop-screen.Lab Chip2021
34787118Evolution of CP2 transcription factors in Hexapoda.J Genet2021
34580286Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers.Cell Death Discov2021
34226567High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia.NPJ Breast Cancer2021
34191294A reasoned approach towards administering COVID-19 vaccines to pregnant women.Prenat Diagn2021
32370157SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2.Cancers (Basel)2020
33116254Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma.Sci Rep2020
33334085Correction: Sundararajan, V., et al. SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2. <i>Cancers</i> 2020, <i>12</i>, 1140.Cancers (Basel)2020
33159134Author Correction: Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity.Commun Biol2020
32609786Functional reservoir microcapsules generated via microfluidic fabrication for long-term cardiovascular therapeutics.Lab Chip2020
32974388Spotlight on the Granules (Grainyhead-Like Proteins) - From an Evolutionary Conserved Controller of Epithelial Trait to Pioneering the Chromatin Landscape.Front Mol Biosci2020
32764731Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity.Commun Biol2020
32529643Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2s.Prenat Diagn2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32209656Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cells.J Biol Chem2020
30527788Reply to Pontus Eriksson and Gottfrid Sjödahl's Letter to the Editor re: Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors. Eur Urol 2019;75:423-32.Eur Urol2019
31861720Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity.Cancers (Basel)2019
31761620Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes.EBioMedicine2019
30213523Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.Eur Urol2019
31372511The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cells.Commun Biol2019
31165775SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition.Sci Rep2019
30939460Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention.Phys Biol2019
30374975Decoding transcriptomic intra-tumour heterogeneity to guide personalised medicine in ovarian cancer.J Pathol2019
30548372The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma.Mol Oncol2019
29255248Dual role of autophagy in hallmarks of cancer.Oncogene2018
29907679The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.EMBO Rep2018
28544151The EMT spectrum and therapeutic opportunities.Mol Oncol2017
29383096Hypoxia-inducible factor-1α promotes cell survival during ammonia stress response in ovarian cancer stem-like cells.Oncotarget2017
28667075AXL-Driven EMT State as a Targetable Conduit in Cancer.Cancer Res2017
28736855'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.Br J Pharmacol2017
28887161Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer.Gene2017
26887977GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.Sci Rep2016
28401178Targeting the AXL signaling pathway in ovarian cancer.Mol Cell Oncol2016
27703030The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer.Sci Signal2016
27735942A new dimension in drug discovery: reversing epithelial-mesenchymal transition (EMT).Cell Death Dis2016
27609069A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.Cancer Lett2016
27622062Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma.Oncoimmunology2016
27368099EMT: 2016.Cell2016
24704825LNK (SH2B3): paradoxical effects in ovarian cancer.Oncogene2015
  • 1 - 50 of 69

Recommended Authors

Kaiyang Zhang
University of Helsinki
Career Start Year 2017
Number of shared co-authors 7
Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 1
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 1
Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 1
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 5
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 3
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 1
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 1
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 0
Bo Gao
Crown Princess Mary Cancer Centre, Westmead Hospital
Career Start Year 2008
Number of shared co-authors 114
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 7
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 1
Aparna Jayachandran
The University of Queensland
Career Start Year 2007
Number of shared co-authors 0
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 0
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Jalna Meens
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Hae-Yun Jung
College of Life Science, CHA University
Career Start Year 2003
Number of shared co-authors 0
Habib Hamidi
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 13
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 1
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 3
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 2
Ernst Lengyel
University of Chicago
Career Start Year 1993
Number of shared co-authors 21
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Anil K Sood
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 24
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 2
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
Ronny Drapkin
University of Pennsylvania School of Medicine
Career Start Year 1980
Number of shared co-authors 60

Collaborators

Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Co-authored papers 37
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Co-authored papers 2
Ernesto Guccione
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Sandra Orsulic
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 2
Cristina Bertocchi
Co-authored papers 2
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Co-authored papers 2
Valerie Rhenius
University of Cambridge
Co-authored papers 1
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 1
Rosalind Glasspool
University of Glasgow
Co-authored papers 1
Chloe Karpinskyj
Institute of Clinical Trials and Methodology, University College London
Co-authored papers 1
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 1
Robert Brown
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 1
Cyril B Gilks
University of British Columbia
Co-authored papers 1
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 1
Helen Steed
University of Alberta, Canada Cross Cancer Institute
Co-authored papers 1
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 1
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 1
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 1
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 1
Aline Talhouk
The University of British Columbia
Co-authored papers 1
Mercedes Jimenez-Linan
University of Cambridge
Co-authored papers 1
Nadia Traficante
Peter MacCallum Cancer Centre
Co-authored papers 1
Derek S Chiu
University of British Columbia, and Vancouver General Hospital
Co-authored papers 1
Gottfried E Konecny
David Geffen School of Medicine at University of California Los Angeles
Co-authored papers 1
Euan A Stronach
Imperial College London
Co-authored papers 1
Sven Mahner
University Hospital
Co-authored papers 1
Chiu-Chen Tseng
Keck School of Medicine, University of Southern California
Co-authored papers 1
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 1
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 1
Release 1.2